PMID- 35803333 OWN - NLM STAT- MEDLINE DCOM- 20220830 LR - 20220830 IS - 1535-6280 (Electronic) IS - 0146-2806 (Linking) VI - 47 IP - 10 DP - 2022 Oct TI - Routine Invasive Strategy in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome: An Updated Systematic Review and Meta-analysis of Randomized Trials. PG - 101304 LID - S0146-2806(22)00201-8 [pii] LID - 10.1016/j.cpcardiol.2022.101304 [doi] AB - Invasive treatment with coronary angiography is preferred approach for patients with non-ST elevation acute coronary syndrome (NSTE-ACS) compared to medical therapy alone. The results from the randomized clinical trials (RCT) that compared the invasive treatment strategy vs. conservative approach in the elderly (>/=75 years) with NSTE-ACS has been inconsistent. To compare invasive and conservative strategies in the elderly (>75 years) with NSTE-ACS. We searched PubMed, Cochrane CENTRAL Register and ClinicalTrials.gov (inception through July 10, 2021) for RCTs comparing invasive and conservative strategies in the elderly with NSTE-ACS. We used random-effects model to calculate risk ratio (RR) with 95% confidence interval(CI). A total of 6 RCT including 2,323 patients were included in the meta-analysis. The median follow-up duration was 13.5 months. When invasive approach was compared to conservative strategy, it showed no difference in all-cause mortality in patients aged >/=75 years with NSTE-ACS (RR of 0.85; 95% CI 0.70-1.04; P = 0.12; I2 = 0%). There was significant reduction in MI (RR 0.59; 95% CI 0.49 0.71; P < 0.001; I2 = 0%) and unplanned revascularization (RR 0.30, 95% CI 0.17-0.53, P <0.001, I2 = 0%). Invasive strategy was associated with higher risk of major bleeding when compared to conservative treatment (RR 2.12, 95% CI 1.21-3.74, P = 0.009, I2 = 0%). Comparison of both strategies showed no significant difference in stroke (RR 0.75; 95% CI 0.38-1.46, P = 0.40; I2 = 0%). This updated meta-analysis suggests that in elderly patients (>75 years) with NSTE-ACS, a routine invasive strategy is associated with a reduction in MI and revascularization, while increasing the risk of major bleeding, but without difference in all-cause mortality and stroke. CI - Published by Elsevier Inc. FAU - Abusnina, Waiel AU - Abusnina W AD - Division of Cardiovascular Diseases, Creighton University School of Medicine, Omaha, NE. Electronic address: dr.abusnina@gmail.com. FAU - Radaideh, Qais AU - Radaideh Q AD - Division of Cardiovascular Diseases, Creighton University School of Medicine, Omaha, NE. FAU - Al-Abdouh, Ahmad AU - Al-Abdouh A AD - Department of Medicine, University of Kentucky, Lexington, KY. FAU - Ismayl, Mahmoud AU - Ismayl M AD - Division of Cardiovascular Diseases, Creighton University School of Medicine, Omaha, NE. FAU - Algheriani, Hedaia AU - Algheriani H AD - Department of Medicine, National Heart center, Tajoura, Libya. FAU - Lee, Juyong AU - Lee J AD - Division of interventional cardiology, University of Connecticut Health Center, Farmington, CT. FAU - Alam, Mahboob AU - Alam M AD - Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX. FAU - Ben-Dor, Itsik AU - Ben-Dor I AD - Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington DC. FAU - Jimenez, Enrique AU - Jimenez E AD - Section of Cardiology, Overton Brooks Veterans Affairs Medical Center, Shreveport, LA. FAU - Azrin, Michael AU - Azrin M AD - Division of interventional cardiology, University of Connecticut Health Center, Farmington, CT. FAU - Paul, Timir K AU - Paul TK AD - Department of medical education, University of Tennessee at Nashville, Nashville, TN. FAU - Dahal, Khagendra AU - Dahal K AD - Division of Cardiovascular Diseases, Creighton University School of Medicine, Omaha, NE. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review PT - Systematic Review DEP - 20220705 PL - Netherlands TA - Curr Probl Cardiol JT - Current problems in cardiology JID - 7701802 SB - IM MH - *Acute Coronary Syndrome MH - Aged MH - Coronary Angiography MH - Humans MH - Myocardial Revascularization MH - Randomized Controlled Trials as Topic MH - *Stroke MH - Treatment Outcome EDAT- 2022/07/09 06:00 MHDA- 2022/08/31 06:00 CRDT- 2022/07/08 19:23 PHST- 2022/06/26 00:00 [received] PHST- 2022/06/28 00:00 [accepted] PHST- 2022/07/09 06:00 [pubmed] PHST- 2022/08/31 06:00 [medline] PHST- 2022/07/08 19:23 [entrez] AID - S0146-2806(22)00201-8 [pii] AID - 10.1016/j.cpcardiol.2022.101304 [doi] PST - ppublish SO - Curr Probl Cardiol. 2022 Oct;47(10):101304. doi: 10.1016/j.cpcardiol.2022.101304. Epub 2022 Jul 5.